---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-025001"
form_type: "8-K"
ticker: null
cik: "0001450416"
company_name: "LexaGene Holdings Inc."
filed_at: "2023-02-24T23:59:59+00:00"
generated_at: "2026-06-19T00:39:13.440478+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# LexaGene files for Chapter 7 bankruptcy, ceases operations and lays off staff

## Summary
- Filed voluntary Chapter 7 petition in U.S. Bankruptcy Court for District of Massachusetts on Feb 24, 2023.
- Company ceased operations and laid off all staff; federal trustee will liquidate assets.
- CEO cites inability to secure funding, market conditions, and slow biopharma sales cycle.
- No liquidation proceeds expected to satisfy all creditors; shareholders unlikely to receive any distribution.
- Subsidiaries LexaGene, Inc. and Bionomics Diagnostics, Inc. included in filing.

## SEC filing metadata
- accession: 0001104659-23-025001
- form_type: 8-K
- cik: 0001450416
- company_name: LexaGene Holdings Inc.
- filed_at: 2023-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1450416/000110465923025001/0001104659-23-025001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1450416/000110465923025001/tm237766d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-025001
- JSON: https://secwatch.observer/filing/0001104659-23-025001.json
- Plain text: https://secwatch.observer/filing/0001104659-23-025001.txt

## Key facts
- Distress & Bankruptcy
  LexaGene Holdings Inc. entered chapter 7 in United States Bankruptcy Court for the District of Massachusetts (petition 2023-02-24).
  - Proceeding: chapter 7
  - Court: United States Bankruptcy Court for the District of Massachusetts
  - Petition: 2023-02-24
  source text: On February 24, 2023, LexaGene Holdings Inc. (the “ Company ”) filed for liquidation under Chapter 7 of Title 11 of the United States Code (the “ Bankruptcy Code ”) in the United States Bankruptcy Court for the District of Massachusetts (the “ Bankruptcy Court ”), located in Boston, Massachusetts.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1450416/000110465923025001/0001104659-23-025001-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.